Comparison of cannabidiol to citalopram in targeting fear memory in female mice.

Background: Cannabidiol (CBD) and selective serotonin reuptake inhibitors (SSRIs) are currently used to treat post-traumatic stress disorder (PTSD). However, these drugs are commonly studied after dosing just prior to extinction training, and there are gaps in our understanding of how they affect fear memory formation, their comparative effects on various types of memory, and of sexual dimorphisms in effects. Also, more studies involving female subjects are needed to balance the gender-inequality in the literature.

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol.

For nearly a century, has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in due to the therapeutic potential of phytocannabinoids. With this emerging interest in , concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing, and packaging processes. This is of particular concern for those turning to for medicinal purposes, especially those with compromised immune systems.